It had to happen: Big Pharma's tax deduction for DTC ads has entered the health-reform debate. Rep. Charles Rangel, chair of House Ways and Means, says Congress could yank that tax break to help
With a new FDA administration in charge, will Americans get new-and-improved DTC ads? And if ads offer improved clarity for consumers, might drugmakers suffer? An analysis in the Los Angeles Times
Pharma coming to an iPhone near you? Apparently, there's an app for that. As Advertising Age notes, iPhone users will soon be able to track their vital signs--blood pressure, glucose level, etc.--and
In examining the marketing of Novartis' Zelnorm, University of North Carolina researchers found that DTC ads for the irritable bowel syndrome med raised awareness of the condition and prompted over
You've seen the drug ad spoofs: Those fake TV commercials that show patients skipping through the tulips, grinning crazily, while a voice-over lists frightening side effects at rapid fire. Well, the
Consumers and doctors crave facts in ads for prescription drugs, and distrust of the pharmaceutical industry has made them skeptical of emotional appeals, according to a new global study from DDB.
At least one big-time pharma attorney isn't amused by the FDA's recent spate of Internet-search-ad warning letters. Though drug-safety concerns top the list of new-FDA worries for Morgan Lewis
Advertising spending among pharmaceutical companies dropped 18.4 percent in 2008, from $5.3 billion to $4.3 billion, due in part to the bleak economic landscape and to a decrease in drugs on the
It's one of the strangest drug ads you'll probably ever see: An attractive young woman explaining why Bayer's birth control pill Yaz isn't all it's cracked up to be. Don't take Yaz thinking you'll
Ding dong, DTC is all but dead? The Pharma Marketing Blog totes up some recent quotes and numbers, concluding that 2009 could be the year consumer advertising will falter in a big way. Evidence?